Immunohistochemical Characterization of Feline Mast Cell Tumors
Open Access
- 4 April 2012
- journal article
- research article
- Published by SAGE Publications in Veterinary Pathology
- Vol. 50 (1) , 106-109
Abstract
Expression of histamine, serotonin, and KIT was evaluated in 61 archived feline mast cell tumors (MCTs) from the skin (n = 29), spleen (n = 17), and gastrointestinal (GI) tract (n = 15) using immunohistochemistry. Twenty-eight percent of cutaneous MCTs, 18% of splenic MCTs, and 53% of GI MCTs displayed histamine immunoreactivity. Serotonin immunoreactivity was detected in 3 GI and 1 cutaneous MCT. Sixty-nine percent of cutaneous MCTs, 35% of splenic MCTs, and 33% of GI MCTs were positive for KIT. Expression of these biogenic amines and KIT was less common than expected. Results of this study suggest heterogeneity in feline MCTs based on anatomic location. Further studies are needed to explain the significance of these differences.Keywords
This publication has 7 references indexed in Scilit:
- Prognostic Value of Histologic and Immunohistochemical Features in Feline Cutaneous Mast Cell TumorsVeterinary Pathology, 2010
- Expression of KIT Receptor in Feline Cutaneous Mast Cell TumorsVeterinary Pathology, 2009
- The Use of KIT and Tryptase Expression Patterns as Prognostic Tools for Canine Cutaneous Mast Cell TumorsVeterinary Pathology, 2004
- C-kit Gene Product (CD117) Immunoreactivity in Canine and Feline Paraffin SectionsJournal of Histochemistry & Cytochemistry, 2004
- Cyclooxygenase-2 Expression in Canine Mammary TumorsVeterinary Pathology, 2003
- Diagnostic and Prognostic Features of Feline Cutaneous Mast Cell Tumours: A Retrospective Analysis of 40 CasesVeterinary Research Communications, 2003
- Distribution, density and heterogeneity of canine mast cells and influence of fixation techniquesHistochemistry and Cell Biology, 1998